Literature DB >> 22189563

The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update.

Hanrui Zhang1, Kevin C Dellsperger, Cuihua Zhang.   

Abstract

Despite abundant clinical evidence linking metabolic abnormalities to diabetic vasculopathy, the molecular basis of individual susceptibility to diabetic vascular complications is still largely undetermined. Endothelial dysfunction in diabetes-associated vascular complications is considered an early stage of vasculopathy and has attracted considerable research interests. Type 2 diabetes is characterized by metabolic abnormalities, such as hyperglycemia, excess liberation of free fatty acids (FFA), insulin resistance and hyperinsulinemia. These abnormalities exert pathological impact on endothelial function by attenuating endothelium-mediated vasomotor function, enhancing endothelial apoptosis, stimulating endothelium activation/endothelium-monocyte adhesion, promoting an atherogenic response and suppressing barrier function. There are multiple signaling pathways contributing to the adverse effects of glucotoxicity on endothelial function. Insulin maintains the normal balance for release of several factors with vasoactive properties. Abnormal insulin signaling in the endothelium does not affect the whole-body glucose metabolism, but impairs endothelial response to insulin and accelerates atherosclerosis. Excessive level of FFA is implicated in the pathogenesis of insulin resistance. FFA induces endothelial oxidative stress, apoptosis and inflammatory response, and inhibits insulin signaling. Although hyperglycemia, insulin resistance, hyperinsulinemia and dyslipidemia independently contribute to endothelial dysfunction via various distinct mechanisms, the mutual interactions may synergistically accelerate their adverse effects. Oxidative stress and inflammation are predicted to be among the first alterations which may trigger other downstream mediators in diabetes associated with endothelial dysfunction. These mechanisms may provide insights into potential therapeutic targets that can delay or reverse diabetic vasculopathy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22189563      PMCID: PMC5512574          DOI: 10.1007/s00395-011-0237-1

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  107 in total

1.  Free fatty acids induce insulin resistance in both cardiac and skeletal muscle microvasculature in humans.

Authors:  Jia Liu; Linda A Jahn; Dale E Fowler; Eugene J Barrett; Wenhong Cao; Zhenqi Liu
Journal:  J Clin Endocrinol Metab       Date:  2010-11-03       Impact factor: 5.958

Review 2.  Endothelial dysfunction as a potential contributor in diabetic nephropathy.

Authors:  Takahiko Nakagawa; Katsuyuki Tanabe; Byron P Croker; Richard J Johnson; Maria B Grant; Tomoki Kosugi; Qiuhong Li
Journal:  Nat Rev Nephrol       Date:  2010-11-02       Impact factor: 28.314

3.  Dose-dependent modulatory effects of insulin on glucose-induced endothelial senescence in vitro and in vivo: a relationship between telomeres and nitric oxide.

Authors:  Hisako Matsui-Hirai; Toshio Hayashi; Seiji Yamamoto; Koichiro Ina; Morihiko Maeda; Hitoshi Kotani; Akihisa Iguchi; Louis J Ignarro; Yuichi Hattori
Journal:  J Pharmacol Exp Ther       Date:  2011-02-28       Impact factor: 4.030

4.  Coronary arterioles in type 2 diabetic (db/db) mice undergo a distinct pattern of remodeling associated with decreased vessel stiffness.

Authors:  Paige S Katz; Aaron J Trask; Flavia M Souza-Smith; Kirk R Hutchinson; Maarten L Galantowicz; Kevin C Lord; James A Stewart; Mary J Cismowski; Kurt J Varner; Pamela A Lucchesi
Journal:  Basic Res Cardiol       Date:  2011-07-10       Impact factor: 17.165

5.  Role of MCP-1 in tumor necrosis factor-alpha-induced endothelial dysfunction in type 2 diabetic mice.

Authors:  Jiyeon Yang; Yoonjung Park; Hanrui Zhang; Xue Gao; Emily Wilson; Warren Zimmer; Louise Abbott; Cuihua Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-07       Impact factor: 4.733

6.  Elevated concentrations of nonesterified fatty acids increase monocyte expression of CD11b and adhesion to endothelial cells.

Authors:  Wei-Yang Zhang; Eric Schwartz; Yingjie Wang; Jeanne Attrep; Zhi Li; Peter Reaven
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-12-15       Impact factor: 8.311

7.  Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db -/-) mice: role of decreased tetrahydrobiopterin bioavailability.

Authors:  Malarvannan Pannirselvam; Subodh Verma; Todd J Anderson; Chris R Triggle
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

8.  Different mechanisms of saturated versus polyunsaturated FFA-induced apoptosis in human endothelial cells.

Authors:  Michaela Artwohl; Andrea Lindenmair; Veronika Sexl; Christina Maier; Georg Rainer; Angelika Freudenthaler; Nicole Huttary; Michael Wolzt; Peter Nowotny; Anton Luger; Sabina M Baumgartner-Parzer
Journal:  J Lipid Res       Date:  2008-08-05       Impact factor: 5.922

9.  Prolonged deterioration of endothelial dysfunction in response to postprandial lipaemia is attenuated by vitamin C in Type 2 diabetes.

Authors:  R A Anderson; L M Evans; G R Ellis; N Khan; K Morris; S K Jackson; A Rees; M J Lewis; M P Frenneaux
Journal:  Diabet Med       Date:  2006-03       Impact factor: 4.359

10.  Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease.

Authors:  Mingzhan Xue; Qingwen Qian; Antonysunil Adaikalakoteswari; Naila Rabbani; Roya Babaei-Jadidi; Paul J Thornalley
Journal:  Diabetes       Date:  2008-07-15       Impact factor: 9.461

View more
  38 in total

1.  Effect of the PPARγ C161T gene variant on serum lipids in ischemic stroke patients with and without type 2 diabetes mellitus.

Authors:  Khouloud Chehaibi; Samir Nouira; Kacem Mahdouani; Sonia Hamdi; Mustapha Rouis; Mohamed Naceur Slimane
Journal:  J Mol Neurosci       Date:  2014-05-21       Impact factor: 3.444

Review 2.  Microvascular dysfunction and efficacy of PDE5 inhibitors in BPH-LUTS.

Authors:  Selim Cellek; Norman E Cameron; Mary A Cotter; Christopher H Fry; Dapo Ilo
Journal:  Nat Rev Urol       Date:  2014-03-11       Impact factor: 14.432

Review 3.  Overlapped metabolic and therapeutic links between Alzheimer and diabetes.

Authors:  Waqar Ahmad
Journal:  Mol Neurobiol       Date:  2012-09-26       Impact factor: 5.590

Review 4.  Blood glucose management in the patient undergoing cardiac surgery: A review.

Authors:  Pingle Reddy; Brian Duggar; John Butterworth
Journal:  World J Cardiol       Date:  2014-11-26

5.  Glucose and palmitate uncouple AMPK from autophagy in human aortic endothelial cells.

Authors:  Karen A Weikel; José M Cacicedo; Neil B Ruderman; Yasuo Ido
Journal:  Am J Physiol Cell Physiol       Date:  2014-10-29       Impact factor: 4.249

6.  Are we waking up to the effects of NEFA?

Authors:  Jonathan C Jun; Vsevolod Y Polotsky
Journal:  Diabetologia       Date:  2015-01-25       Impact factor: 10.122

7.  Coronary endothelial dysfunction and mitochondrial reactive oxygen species in type 2 diabetic mice.

Authors:  Young-Eun Cho; Aninda Basu; Anzhi Dai; Michael Heldak; Ayako Makino
Journal:  Am J Physiol Cell Physiol       Date:  2013-08-28       Impact factor: 4.249

8.  Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus.

Authors:  Steven P Moberly; Kieren J Mather; Zachary C Berwick; Meredith K Owen; Adam G Goodwill; Eli D Casalini; Gary D Hutchins; Mark A Green; Yen Ng; Robert V Considine; Kevin M Perry; Robin L Chisholm; Johnathan D Tune
Journal:  Basic Res Cardiol       Date:  2013-06-14       Impact factor: 17.165

Review 9.  Management of dyslipidemias in the presence of the metabolic syndrome or type 2 diabetes.

Authors:  Niina Matikainen; Marja-Riitta Taskinen
Journal:  Curr Cardiol Rep       Date:  2012-12       Impact factor: 2.931

10.  Diabetes and stroke prevention: a review.

Authors:  Jonathan Hewitt; Luis Castilla Guerra; María Del Carmen Fernández-Moreno; Cristina Sierra
Journal:  Stroke Res Treat       Date:  2012-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.